These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

241 related items for PubMed ID: 21510764

  • 1. Metabolomics in urogenital cancer.
    Bujak R, Daghir E, Rybka J, Koslinski P, Markuszewski MJ.
    Bioanalysis; 2011 Apr; 3(8):913-23. PubMed ID: 21510764
    [Abstract] [Full Text] [Related]

  • 2. Cancer biomarker discovery: Opportunities and pitfalls in analytical methods.
    Issaq HJ, Waybright TJ, Veenstra TD.
    Electrophoresis; 2011 Apr; 32(9):967-75. PubMed ID: 21449066
    [Abstract] [Full Text] [Related]

  • 3. Metabolomics: a new tool for the neonatologist.
    Atzori L, Antonucci R, Barberini L, Griffin JL, Fanos V.
    J Matern Fetal Neonatal Med; 2009 Apr; 22 Suppl 3():50-3. PubMed ID: 19701858
    [Abstract] [Full Text] [Related]

  • 4. A comprehensive urinary metabolomic approach for identifying kidney cancerr.
    Kind T, Tolstikov V, Fiehn O, Weiss RH.
    Anal Biochem; 2007 Apr 15; 363(2):185-95. PubMed ID: 17316536
    [Abstract] [Full Text] [Related]

  • 5. Metabolic profiling of human colorectal cancer using high-resolution magic angle spinning nuclear magnetic resonance (HR-MAS NMR) spectroscopy and gas chromatography mass spectrometry (GC/MS).
    Chan EC, Koh PK, Mal M, Cheah PY, Eu KW, Backshall A, Cavill R, Nicholson JK, Keun HC.
    J Proteome Res; 2009 Jan 15; 8(1):352-61. PubMed ID: 19063642
    [Abstract] [Full Text] [Related]

  • 6. Metabolomic study for diagnostic model of oesophageal cancer using gas chromatography/mass spectrometry.
    Wu H, Xue R, Lu C, Deng C, Liu T, Zeng H, Wang Q, Shen X.
    J Chromatogr B Analyt Technol Biomed Life Sci; 2009 Oct 01; 877(27):3111-7. PubMed ID: 19716777
    [Abstract] [Full Text] [Related]

  • 7. Metabolome analysis for discovering biomarkers of gastroenterological cancer.
    Suzuki M, Nishiumi S, Matsubara A, Azuma T, Yoshida M.
    J Chromatogr B Analyt Technol Biomed Life Sci; 2014 Sep 01; 966():59-69. PubMed ID: 24636738
    [Abstract] [Full Text] [Related]

  • 8. Global proteomics and metabolomics in cancer biomarker discovery.
    Issaq HJ, Fox SD, Chan KC, Veenstra TD.
    J Sep Sci; 2011 Dec 01; 34(24):3484-92. PubMed ID: 22102289
    [Abstract] [Full Text] [Related]

  • 9. Mass spectrometry-based clinical proteomics: head-and-neck cancer biomarkers and drug-targets discovery.
    Matta A, Ralhan R, DeSouza LV, Siu KW.
    Mass Spectrom Rev; 2010 Dec 01; 29(6):945-61. PubMed ID: 20945361
    [Abstract] [Full Text] [Related]

  • 10. Serum metabolomics as a novel diagnostic approach for gastrointestinal cancer.
    Ikeda A, Nishiumi S, Shinohara M, Yoshie T, Hatano N, Okuno T, Bamba T, Fukusaki E, Takenawa T, Azuma T, Yoshida M.
    Biomed Chromatogr; 2012 May 01; 26(5):548-58. PubMed ID: 21773981
    [Abstract] [Full Text] [Related]

  • 11. Altered levels of nucleoside metabolite profiles in urogenital tract cancer measured by capillary electrophoresis.
    Szymańska E, Markuszewski MJ, Markuszewski M, Kaliszan R.
    J Pharm Biomed Anal; 2010 Dec 15; 53(5):1305-12. PubMed ID: 20719449
    [Abstract] [Full Text] [Related]

  • 12. Advances in metabolite identification.
    Wishart DS.
    Bioanalysis; 2011 Aug 15; 3(15):1769-82. PubMed ID: 21827274
    [Abstract] [Full Text] [Related]

  • 13. Metabolomics in biomarker discovery: future uses for cancer prevention.
    Kim YS, Maruvada P, Milner JA.
    Future Oncol; 2008 Feb 15; 4(1):93-102. PubMed ID: 18241004
    [Abstract] [Full Text] [Related]

  • 14. Metabolomics: the "new clinical chemistry" for personalized neonatal medicine.
    Antonucci R, Atzori L, Barberini L, Fanos V.
    Minerva Pediatr; 2010 Jun 15; 62(3 Suppl 1):145-8. PubMed ID: 21089734
    [Abstract] [Full Text] [Related]

  • 15. Proteomic approaches in lung cancer biomarker development.
    Cho JY, Sung HJ.
    Expert Rev Proteomics; 2009 Feb 15; 6(1):27-42. PubMed ID: 19210125
    [Abstract] [Full Text] [Related]

  • 16. Metabonomics of human colorectal cancer: new approaches for early diagnosis and biomarker discovery.
    Ni Y, Xie G, Jia W.
    J Proteome Res; 2014 Sep 05; 13(9):3857-70. PubMed ID: 25105552
    [Abstract] [Full Text] [Related]

  • 17. Detection of bladder cancer in human urine by metabolomic profiling using high performance liquid chromatography/mass spectrometry.
    Issaq HJ, Nativ O, Waybright T, Luke B, Veenstra TD, Issaq EJ, Kravstov A, Mullerad M.
    J Urol; 2008 Jun 05; 179(6):2422-6. PubMed ID: 18433783
    [Abstract] [Full Text] [Related]

  • 18. Challenges and developments in tandem mass spectrometry based clinical metabolomics.
    Ceglarek U, Leichtle A, Brügel M, Kortz L, Brauer R, Bresler K, Thiery J, Fiedler GM.
    Mol Cell Endocrinol; 2009 Mar 25; 301(1-2):266-71. PubMed ID: 19007853
    [Abstract] [Full Text] [Related]

  • 19. NMR-based metabolomics approach to target biomarkers for human prostate cancer.
    Jordan KW, Cheng LL.
    Expert Rev Proteomics; 2007 Jun 25; 4(3):389-400. PubMed ID: 17552923
    [Abstract] [Full Text] [Related]

  • 20. Recent advances in metabolomics in oncology.
    O'Connell TM.
    Bioanalysis; 2012 Feb 25; 4(4):431-51. PubMed ID: 22394143
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.